Assignee
INSYS DEV CO INC
US·21 granted patents·13 pending applications·92 citations·filing 2015–2019
Top patents by PatentIndex Score
34 records- 0196US10441538B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2018·Granted Oct 15, 2019·16 cites·10 claims
- 0296US10039710B2Epinephrine spray formulationsINSYS DEV CO INC·Filed 2017·Granted Aug 7, 2018·27 cites·27 claims
- 0394US10722510B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2016·Granted Jul 28, 2020·10 cites·7 claims
- 0494US10617686B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2017·Granted Apr 14, 2020·13 cites·5 claims
- 0592US9918981B2Liquid buprenorphine formulationsINSYS DEV CO INC·Filed 2016·Granted Mar 20, 2018·6 cites·20 claims
- 0692US9839611B2Sublingual buprenorphine sprayINSYS DEV CO INC·Filed 2015·Granted Dec 12, 2017·7 cites·18 claims
- 0791US11077075B2Methods of stabilizing epinephrineINSYS DEV CO INC·Filed 2019·Granted Aug 3, 2021·5 cites·16 claims
- 0883US9642844B2Sublingual fentanyl sprayINSYS DEV CO INC·Filed 2015·Granted May 9, 2017·3 cites·21 claims
- 0977US10016403B2Sublingual fentanyl sprayINSYS DEV CO INC·Filed 2017·Granted Jul 10, 2018·1 cites·2 claims
- 1076US10265309B2Sublingual opioid formulations containing naloxoneINSYS DEV CO INC·Filed 2017·Granted Apr 23, 2019·1 cites·2 claims
- 1174US10265293B2Oral cannabinoid formulationsINSYS DEV CO INC·Filed 2016·Granted Apr 23, 2019·1 cites·5 claims
- 1274US10111833B2Sildenafil sublingual spray formulationsINSYS DEV CO INC·Filed 2017·Granted Oct 30, 2018·1 cites·17 claims
- 1372US9662334B2Sildenafil sublingual spray formulationsINSYS DEV CO INC·Filed 2016·Granted May 30, 2017·1 cites·19 claims
- 1470US10966925B2Epinephrine spray formulationsINSYS DEV CO INC·Filed 2019·Granted Apr 6, 2021·0 cites·10 claims
- 1568US10610523B2Sublingual fentanyl sprayINSYS DEV CO INC·Filed 2017·Granted Apr 7, 2020·0 cites·1 claims
- 1664US2018303813A1Sublingual fentanyl sprayINSYS DEV CO INC·Filed 2018·Application pending·0 cites
- 1763US10874658B2Sublingual opioid formulations containing naloxoneINSYS DEV CO INC·Filed 2019·Granted Dec 29, 2020·0 cites·16 claims
- 1861US9642797B2Sublingual fentanyl spray and methods of use to treat painINSYS DEV CO INC·Filed 2016·Granted May 9, 2017·0 cites·4 claims
- 1960US11053037B2System and method for purging oxygen from medical vialsINSYS DEV CO INC·Filed 2018·Granted Jul 6, 2021·0 cites·5 claims
- 2056US2020009472A1Disposal System for Unused PharmaceuticalsINSYS DEV CO INC·Filed 2019·Application pending·0 cites
- 2155US10172833B2Sublingual ondansetron sprayINSYS DEV CO INC·Filed 2016·Granted Jan 8, 2019·0 cites·16 claims
- 2252US2016367496A1Stable cannabinoid formulationsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 2349US2019209517A1Methods of stabilizing dronabinolINSYS DEV CO INC·Filed 2019·Application pending·0 cites
- 2448US9867818B2Sublingual buprenorphine sprayINSYS DEV CO INC·Filed 2016·Granted Jan 16, 2018·0 cites·11 claims
- 2548US2018153795A1Liquid buprenorphine formulationsINSYS DEV CO INC·Filed 2018·Application pending·0 cites
- 2647US2016361667A1Disposal System for Unused PharmaceuticalsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 2745US2017105970A1Ondansetron sublingual spray formulationINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 2843US2017079907A1Sublingual Epinephrine SprayINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 2942US2016199294A1Sublingual naloxone sprayINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3042US2019224171A1Liquid rizatriptan compositionsINSYS DEV CO INC·Filed 2019·Application pending·0 cites
- 3141US2016271252A1Stable cannabinoid formulationsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3240US2017340557A1Sublingual fentanyl formulations containing a permeation enhancerINSYS DEV CO INC·Filed 2017·Application pending·0 cites
- 3339US10414578B2Actuator for a package and method of useINSYS DEV CO INC·Filed 2018·Granted Sep 17, 2019·0 cites·10 claims
- 3439US2016296498A1Ketorolac Sublingual Spray FormulationsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →